-+ 0.00%
-+ 0.00%
-+ 0.00%

TSCAN THERAPEUTICS ANNOUNCES POSITIVE UPDATED DATA FROM THE ALLOHA™ PHASE 1 HEME TRIAL AT THE 67TH AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING AND EXPOSITION

Reuters·12/06/2025 22:30:02

Please log in to view news